
Chemical and Pharmaceutical Bulletin p. 1468 - 1473 (1998)
Update date:2022-07-30
Topics:
Suzuki, Takeshi
Nagaoka, Hitoshi
Kondo, Yutaka
Takahashi, Takumi
Takeuchi, Makoto
Hara, Hiromu
Saito, Munetoshi
Yamada, Toshimitsu
Tomioka, Kenichi
Hamada, Mamoru
Mase, Toshiyasu
Conversion of the 2-(3-pyridyl)thiazolidine part of 1-(3-phenylpropyl)- 4-[2-(3-pyridyl)thiazolidine-4-carbonyl]piperazine (YM461), which is a potent platelet-activating factor (PAF) antagonist, to other rings was performed, and PAF antagonistic activitie
View MoreHangzhou J&H Chemical Co., Ltd.
website:http://www.jhechem.com/
Contact:+86-571-87396432
Address:No.200 Zhenhua Rd.Xihu Industrial Park, Hangzhou 310030, China
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
ZHUHAI HAIRUIDE BIOSCIENCE AND TECHNOLOGY CO.,LTD
website:http://www.zhhairuide.com
Contact:+8613326687259/+86-756-7789199
Address:No.10 Yonghui Road
Hefei Lifeon Pharmaceutical Co., Ltd.
Contact:+86-551-65328450
Address:No522 Wangjiang West Road
Shanghai Yuking Water Soluble Material Tech Co., Ltd
Contact:86-21-68286299
Address:4F, 13B, No. 600, South Xinyuan Road 201306, Shanghai, China
Doi:10.1021/jo000210u
(2000)Doi:10.1021/ol000072v
(2000)Doi:10.1139/v70-348
(1970)Doi:10.1021/ja001958x
(2000)Doi:10.1002/1099-0682(200007)2000:7<1523::AID-EJIC1523>3.0.CO;2-2
(2000)Doi:10.1016/S0040-4039(01)87376-7
(1973)